Skip to main content
Premium Trial:

Request an Annual Quote

Verge Genomics Raises $4M in Seed Financing

NEW YORK (GenomeWeb) – Startup drug discovery firm Verge Genomics today announced it has raised $4 million in seed funding.

IA Ventures led the round, joined by Two Sigma Ventures, Draper Associates, Great Oaks VC, Slow Ventures, Karlin Ventures, and other private investors. San Francisco-based Verge came out of the Y Combinator accelerator and is also a spinout of the University of California, Los Angeles.

The firm is looking to change drug development for neurodegenerative diseases by using algorithms to find the gene networks contributing to those diseases and matching drugs that can affect the entire network.

Verge said in a statement that it will use the proceeds to expand development on its leading algorithmic platform while advancing lead drug candidates through further preclinical proof-of-concept experiments.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.